Related Experiment Video
Updated: Feb 28, 2026
08:21
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
2.1K
Mendelian randomisation in cardiovascular research: an introduction for clinicians
Derrick A Bennett1, Michael V Holmes1,2,3
1Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Heart (British Cardiac Society)
|June 10, 2017
Summary
Mendelian randomization uses genetic data to reliably assess biomarker causality in disease, aiding drug development. This method helps prioritize cardiovascular drug targets and avoid costly clinical trial failures.
Area of Science:
- Cardiovascular Research
- Pharmacological Therapies
- Biomarker Discovery
Background:
- Classical observational studies offer biased estimates of biomarker roles in disease.
- Drug development faces costly failures when targets are non-causal biomarkers.
- Reliable biomarker causality assessment is vital for effective disease treatment and prevention.
Purpose of the Study:
- To review the utility of Mendelian randomization for clinicians in cardiovascular research.
- To describe the rationale, methods, and limitations of Mendelian randomization.
- To highlight Mendelian randomization's role in drug discovery and target prioritization.
Main Methods:
- Narrative review of Mendelian randomization studies.
- Description of Mendelian randomization principles and potential limitations.
- Inclusion of literature examples demonstrating Mendelian randomization applications.
Main Results:
- Mendelian randomization provides a more reliable indication of biomarker causality.
- Examples show its pivotal role in predicting drug efficacy.
- It informs on target-mediated adverse effects and aids drug repurposing.
Conclusions:
- Mendelian randomization is crucial for prioritizing drug targets in cardiovascular research.
- It mitigates risks associated with non-causal biomarkers in drug development.
- This genetic approach enhances the reliability of biomarker-disease association studies.
Related Concept Videos
01:13Randomized Experiments
9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.1K
02:01Group Design
10.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.9K
01:12What is an Experiment?
19.3K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
19.3K
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
309
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
309
01:27Principles of Pharmacogenetics: Types of Genetic Variants
60
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
60
01:52Regression Toward the Mean
7.2K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K